Follow us on social media for our latest updates. Targeting Tau to keep neurons connected 19/01/2021 An international team of researchers led by Patrik Verstreken at VIB-KU Leuven has succeeded in reversing the effects of Tau, a protein implicated in over 20 different diseases, including Alzheimer’s disease. Genetics reveals the link between blood insulin and gender: one size doesn’t fit all 11/01/2021 Researchers from the University of Surrey, VIB-KU Leuven, University of Lille, and a number of other institutions examined DNA variations in 151,188 Europeans without diabetes, to determine whether genetic differences can explain the known gender differences in how well the body is able to manage blood sugar and insulin levels. Brain enzyme caught in the act 18/12/2020 Researchers from the lab of Wim Versées (VIB-VUB) in collaboration with the team of Patrik Verstreken (VIB-KU Leuven) presents the three-dimensional structure of an enzyme involved in Parkinson’s disease, epilepsy, Alzheimer's disease, and Down syndrome. New European alliance formed to tackle urgent challenge of neurodegenerative diseases 17/12/2020 Top research institutes from Germany, France, Belgium and the UK have formed a new alliance to combat neurodegenerative diseases. Their mission? Catalyzing a United Response in Europe to Neurodegenerative Diseases, or CURE-ND for short. ALS Eyes Challenge 08/12/2020 This year the ALS League, comes with a new challenge for De Warmste Week! One with which we can mark one of our points on our Bucket List! 19 VIB researchers among the most highly cited researchers 23/11/2020 Each year, Clarivate publishes a ‘highly cited researchers’ list recognizing pioneers in their field. This list contains researchers who have demonstrated significant influence through the publication of multiple papers, highly cited by their peers, during the last decade (2009-2019). No less than 19 VIB researchers are part of this highly acclaimed group of influential scientists. Dissecting the immune characteristics of severe COVID-19 responses 16/11/2020 A team of immunology experts at VIB, KU Leuven, UZ Leuven and ULB in Belgium and the Babraham Institute in the UK have come together study this diversity in COVID-19 responses. This understanding is crucial to guide the development of effective healthcare and ‘early-warning’ systems to identify and treat those at risk of a severe response New players at the synapse 15/10/2020 A research team led by Joris de Wit at the VIB-KU Leuven Center for Brain & Disease Research has uncovered new molecular players critical for the formation and function of neuronal circuits in the brain. Through proteomic profiling of a specific synapse in the hippocampus, they identified multiple uncharacterized synaptic cell surface proteins, including a new regulator of connectivity. From genetic risk to drug targets for Alzheimer’s disease 02/10/2020 In this week’s edition of Science, researchers at VIB and the UK DRI highlight the need for a better understanding of the environmental and genetic risks of Alzheimer’s disease. Gene variants should be studied in the right cell types and in the right context, they argue, if we want to make progress in our search for effective therapies. New VIB PI Renzo Mancuso wins European Grand Prix for Alzheimer's research 21/09/2020 Every year on World Alzheimer's Day, the French organization: Fondation Recherche Alzheimer honors top European researchers who have made an important contribution to research into the disease. The prize for "most promising young researcher" is awarded this year to two young talents, including Renzo Mancuso: an Argentinian scientist affiliated to VIB and the universities of Leuven and Antwerp. Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 Next page Next ›
Targeting Tau to keep neurons connected 19/01/2021 An international team of researchers led by Patrik Verstreken at VIB-KU Leuven has succeeded in reversing the effects of Tau, a protein implicated in over 20 different diseases, including Alzheimer’s disease.
Genetics reveals the link between blood insulin and gender: one size doesn’t fit all 11/01/2021 Researchers from the University of Surrey, VIB-KU Leuven, University of Lille, and a number of other institutions examined DNA variations in 151,188 Europeans without diabetes, to determine whether genetic differences can explain the known gender differences in how well the body is able to manage blood sugar and insulin levels.
Brain enzyme caught in the act 18/12/2020 Researchers from the lab of Wim Versées (VIB-VUB) in collaboration with the team of Patrik Verstreken (VIB-KU Leuven) presents the three-dimensional structure of an enzyme involved in Parkinson’s disease, epilepsy, Alzheimer's disease, and Down syndrome.
New European alliance formed to tackle urgent challenge of neurodegenerative diseases 17/12/2020 Top research institutes from Germany, France, Belgium and the UK have formed a new alliance to combat neurodegenerative diseases. Their mission? Catalyzing a United Response in Europe to Neurodegenerative Diseases, or CURE-ND for short.
ALS Eyes Challenge 08/12/2020 This year the ALS League, comes with a new challenge for De Warmste Week! One with which we can mark one of our points on our Bucket List!
19 VIB researchers among the most highly cited researchers 23/11/2020 Each year, Clarivate publishes a ‘highly cited researchers’ list recognizing pioneers in their field. This list contains researchers who have demonstrated significant influence through the publication of multiple papers, highly cited by their peers, during the last decade (2009-2019). No less than 19 VIB researchers are part of this highly acclaimed group of influential scientists.
Dissecting the immune characteristics of severe COVID-19 responses 16/11/2020 A team of immunology experts at VIB, KU Leuven, UZ Leuven and ULB in Belgium and the Babraham Institute in the UK have come together study this diversity in COVID-19 responses. This understanding is crucial to guide the development of effective healthcare and ‘early-warning’ systems to identify and treat those at risk of a severe response
New players at the synapse 15/10/2020 A research team led by Joris de Wit at the VIB-KU Leuven Center for Brain & Disease Research has uncovered new molecular players critical for the formation and function of neuronal circuits in the brain. Through proteomic profiling of a specific synapse in the hippocampus, they identified multiple uncharacterized synaptic cell surface proteins, including a new regulator of connectivity.
From genetic risk to drug targets for Alzheimer’s disease 02/10/2020 In this week’s edition of Science, researchers at VIB and the UK DRI highlight the need for a better understanding of the environmental and genetic risks of Alzheimer’s disease. Gene variants should be studied in the right cell types and in the right context, they argue, if we want to make progress in our search for effective therapies.
New VIB PI Renzo Mancuso wins European Grand Prix for Alzheimer's research 21/09/2020 Every year on World Alzheimer's Day, the French organization: Fondation Recherche Alzheimer honors top European researchers who have made an important contribution to research into the disease. The prize for "most promising young researcher" is awarded this year to two young talents, including Renzo Mancuso: an Argentinian scientist affiliated to VIB and the universities of Leuven and Antwerp.
